Association analysis of polymorphic CGG repeat in 5′ UTR of the reelin and VLDLR genes with schizophrenia

Schizophrenia Research

Volumn 58, Issue 1, 2002, Pages 37-41

  Akahane, Akihisa ^a   Kunugi, Hiroshi ^a   Tanaka, Hiroshi ^a   Nanko, Shinichiro ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Association study; Neurodevelopment; Reelin; Schizophrenia; Trinucleotide repeat; Very low density lipoprotein receptor (VLDLR)

Indexed keywords

REELIN; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

5' UNTRANSLATED REGION; ADULT; ALZHEIMER DISEASE; ARTICLE; AUTISM; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNIC GROUP; FEMALE; GENETIC ASSOCIATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; TRINUCLEOTIDE REPEAT;

5' FLANKING REGION; ADULT; ALLELES; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES, NEURONAL; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; MALE; NERVE TISSUE PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, LDL; RISK FACTORS; SCHIZOPHRENIA; SEQUENCE ANALYSIS, DNA; SERINE ENDOPEPTIDASES; TRINUCLEOTIDE REPEATS;

EID: 0036844074     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00398-X     Document Type: Article

References (22)

1. Bayer T.A., Falkai P., Maier W. Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis" J. Psychiatr. Res. 33:1999;543-548.
2. Chung H., Roberts C.T., Greenberg S., Rebeck G.W., Christie R., Wallace R., Jacob H.J., Hyman B.T. Lack of association of trinucleotide repeat polymorphisms in very-low-density lipoprotein receptor gene with Alzheimer's disease. Ann. Neurol. 39:1996;800-803.
3. Curran T., D'Arcangelo G. Role of reelin in the control of brain development. Brain Res. Brain Res. Rev. 26:1998;285-294.
4. D'Arcangelo G., Homayouni R., Keshvara L., Rice D.S., Sheldon M., Curran T. Reelin is a ligand for lipoprotein receptors. Neuron. 24:1999;471-479.
5. DeSilva U., D'Arcangelo G., Braden V.V., Chen J., Miao G.G., Curran T., Green E.D. The human reelin gene: isolation, sequencing, and mapping on chromosome 7. Genome Res. 7:1997;157-164.
6. Ekelund J., Lichtermann D., Hovatta I., Ellonen P., Suvisaari J., Terwilliger J.D., Juvonen H., Varilo T., Arajarvi R., Kokko-Sahin M.L., Lonnqvist J., Peltonen L. Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. Hum. Mol. Genet. 9:2000;1049-1057.
7. Fatemi S.H. Reelin mutations in mouse and man: from reeler mouse to schizophrenia, mood disorders, autism and lissencephaly. Mol. Psychiatry. 6:2001;129-133.
8. Fatemi S.H., Earle J.A., McMenomy T. Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol. Psychiatry. 5:2000;654-663.
9. Goffinet A.M. An early development defect in the cerebral cortex of the reeler mouse: a morphological study leading to a hypothesis concerning the action of the mutant gene. Anat. Embryol. 157:1979;205-216.
10. Guidotti A., Auta J., Davis J.M., DiGiorgi Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., Uzunov D., Costa E. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry. 57:2000;1061-1069.
11. Helbecque N., Amouyel P. Very low density lipoprotein receptor in Alzheimer disease. Microsc. Res. Tech. 50:2000;273-277.
12. Helbecque N., Richard F., Cottel D., Neuman E., Guez D., Amouyel P. The very low density lipoprotein (VLDL) receptor is a genetic susceptibility factor for Alzheimer disease in a European Caucasian population. Alzheimer Dis. Assoc. Disord. 12:1998;368-371.
13. Hovatta I., Varilo T., Suvisaari J., Terwilliger J.D., Ollikainen V., Arajarvi R., Juvonen H., Kokko-Sahin M.L., Vaisanen L., Mannila H., Lonnqvist J., Peltonen L. A genome-wide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am. J. Hum. Genet. 65:1999;1114-1124.
14. Impagnatiello F., Guidotti A.R., Pesold C., Dwivedi Y., Caruncho H., Pisu M.G., Uzunov D.P., Smalheiser N.R., Davis J.M., Pandey G.N., Pappas G.D., Tueting P., Sharma R.P., Costa E. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 95:1998;15718-15723.
15. Oka K., Tzung K.-W., Sullivan M., Lindsay E., Baldini A., Chan L. Human very-low-density lipoprotein receptor complementary DNA and deduced amino acid sequence and localization of its gene (VLDLR) to chromosome band 9q24 by fluorescence in situ hybridization. Genomics. 20:1994;298-300.
16. Okuizumi K., Onodera O., Namba Y., Ikeda K., Yamamoto T., Seki K., Ueki A., Nanko S., Tanaka H., Takahashi H., Oyanagi K., Mizusawa H., Kanazawa I., Tsuji S. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nat. Genet. 11:1995;207-209.
17. Okuizumi K., Onodera O., Seki K., Tanaka H., Namba Y., Ikeda K., Saunders A.M., Pericak-Vance M.A., Roses A.D., Tsuji S. Lack of Association of very low density lipoprotein receptor gene polymorphism with Caucasian Alzheimer's disease. Ann. Neurol. 40:1996;251-254.
18. Ott J. Analysis of Human Genetic Linkage. 3rd edn. 1999;Johns Hopkins Univ. Press, Baltimore.
19. Persico A.M., D'Agruma L., Maiorano N., Totaro A., Militerni R., Bravaccio C., Wassink T.H., Schneider C., Melmed R., Trillo S., Montecchi F., Palermo M., Pascucci T., Puglisi-Allegra S., Reichelt K.L., Conciatori M., Marino R., Quattrocchi C.C., Baldi A., Zelante L., Gasparini P., Keller F. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol. Psychiatry. 6:2001;150-159.
20. Sham P.C., Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann. Hum. Genet. 59:1995;97-105.
21. Trommsdorff M., Gotthardt M., Hiesberger T., Shelton J., Stockinger W., Nimpf J., Hammer R.E., Richardson J.A., Herz J. Reeler/disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell. 97:1999;689-701.
22. Yamanaka H., Kamimura K., Tanahashi H., Takahashi K., Asada T., Tabira T. Genetic risk factors in Japanese Alzheimer's disease patients: alpha1-ACT, VLDLR, and ApoE. Neurobiol. Aging. 19(1 Suppl.):1998;S43-S46.